• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHAO Shijuan,YAN Jiarui,SHI Ting,YAN Zhen,YIN Lifang.Preparation and In vitro Release of Mesalamine Delayed-release Tablets[J].Journal Of Pharmaceutical Research,2021,40(7):452-457[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2722times   Download 2460次 QR Code for this article
Scan with your phone!
美沙拉嗪肠溶缓释片的制备与体外释放度考察
赵世娟,严家瑞,史婷,严真,尹莉芳
Font:Larger+|Default|Smaller-
(中国药科大学药学院药剂系,江苏省缓释智能制剂及关键功能性辅料开发与评价工程研究中心,江苏 南京 210009)
摘要:
目的 制备美沙拉嗪肠溶缓释片,考察其体外释放。方法 以体外释放相似因子(f2)为主要评价指标,通过单因素处方筛选和正交试验设计得到最优处方,重现三批,比较自制美沙拉嗪肠溶缓释片与参比制剂的体外释放行为。 结果 片芯中羧甲基纤维素钠(CMC 7HXF PH)用量为45 mg,羧甲淀粉钠(CMSNa)用量为35 mg;肠溶包衣层中Eudragit L100和Eudragit S100以2:3的比例联用,包衣增重为6%。自制肠溶缓释片与参比制剂的相似因子f2值均大于50。 结论 自制美沙拉嗪肠溶缓释片与参比制剂体外释放相似,处方工艺稳定可重现,可用于美沙拉嗪肠溶缓释片的制备。
关键词:  美沙拉嗪  缓释片  肠溶包衣  体外释放
DOI:10.13506/j.cnki.jpr.2021.07.007
基金项目:国家科技重大专项“重大新药创制”项目(No.2017ZX09101001-004)
Preparation and In vitro Release of Mesalamine Delayed-release Tablets
ZHAO Shijuan,YAN Jiarui,SHI Ting,YAN Zhen,YIN Lifang
(Department of Pharmaceutics, School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China; Engineering Research Center for Development and Evaluation of Sustained-Release intelligent Preparations and Key Functional Excipients of Jiangsu Province,Nanjing 210009,China)
Abstract:
Objective To prepare mesalamine delayed-release tablets and investigate the in vitro release behaviors. Methods With the similarity factor (f2) in vitro release as the evaluation index,the optimal formulation was determined by single factor experiments and orthogonal experiments. Three batches of mesalamine delayed-release tablets were reproduced and compared with the reference listed drug. Results The amount of sodium carboxymethylcellulose(CMC 7HXF PH) was 45mg and the amount of sodium starch glycolate(CMSNa) was 35mg in the tablet core. The ratio of Eudragit L100 to Eudragit S100 was 2:3 and the coating weight gain was 6% in the enteric coating shell. The f2 values were all greater than 50. Conclusion The release behaviors of the self-made mesalamine delayed-release tablets and the reference listed drug are similar. The formulation and preparation process are stable and reproducible,which can be applied to prepare mesalamine delayed-release tablets .
Key words:  Mesalamine  Delayed-release Tablets  Enteric coating  In vitro release
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.